| http://dbpedia.org/ontology/abstract
|
MIN-117 (known formerly as WF-516) is an i … MIN-117 (known formerly as WF-516) is an investigational antidepressant which is under development by for the clinical treatment of major depressive disorder (MDD). It is described as a 5-HT1A and 5-HT2A receptor antagonist and inhibitor of serotonin and dopamine reuptake, and is also reported to possess affinity for the α1A- and α1B-adrenergic receptors. As of May 2015, MIN-117 is in phase II clinical trials for MDD. In December 2019, Minerva announced that MIN-117 was no longer in clinical development for MDD after disappointing results in a phase IIb trial.isappointing results in a phase IIb trial.
|
| http://dbpedia.org/ontology/casNumber
|
310392-94-0
|
| http://dbpedia.org/ontology/fdaUniiCode
|
QM05G7NM4H
|
| http://dbpedia.org/ontology/pubchem
|
9806065
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/MIN-117.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://web.archive.org/web/20150520033706/http:/files.shareholder.com/downloads/AMDA-2MIFBM/0x0x813311/13B96B22-1D5F-470D-888B-8E1F47FE6AFA/Minerva_Investor_Presentation_-_March_2015.pdf +
, http://adisinsight.springer.com/drugs/800037483 +
, http://www.minervaneurosciences.com/innovation-pipeline/min-117/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
46752641
|
| http://dbpedia.org/ontology/wikiPageLength
|
6003
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1085647288
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Alpha-1A_adrenergic_receptor +
, http://dbpedia.org/resource/Category:Benzofuran_ethers_at_the_benzene_ring +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Reuptake +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Major_depressive_disorder +
, http://dbpedia.org/resource/Minerva_Neurosciences +
, http://dbpedia.org/resource/Antidepressant +
, http://dbpedia.org/resource/Reuptake_inhibitor +
, http://dbpedia.org/resource/5-HT2A_receptor +
, http://dbpedia.org/resource/Category:5-HT2A_antagonists +
, http://dbpedia.org/resource/5-HT1A_receptor +
, http://dbpedia.org/resource/Affinity_%28pharmacology%29 +
, http://dbpedia.org/resource/List_of_investigational_antidepressants +
, http://dbpedia.org/resource/Dopamine +
, http://dbpedia.org/resource/Category:5-HT1A_antagonists +
, http://dbpedia.org/resource/Alpha-1B_adrenergic_receptor +
, http://dbpedia.org/resource/Serotonin +
, http://dbpedia.org/resource/Category:4-Phenylpiperidines +
|
| http://dbpedia.org/property/c
|
25
|
| http://dbpedia.org/property/casNumber
|
310392
|
| http://dbpedia.org/property/chemspiderid
|
7981825
|
| http://dbpedia.org/property/cl
|
2
|
| http://dbpedia.org/property/h
|
25
|
| http://dbpedia.org/property/iupacName
|
-1
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
9806065
|
| http://dbpedia.org/property/smiles
|
CC1=NN=CC2=CC3=CC=CC=C3OC[C@H]O
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
XIYDIPLATGRHEC-SFHVURJKSA-N
|
| http://dbpedia.org/property/synonyms
|
WF-516
|
| http://dbpedia.org/property/unii
|
QM05G7NM4H
|
| http://dbpedia.org/property/width
|
250
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Serotonin_receptor_modulators +
, http://dbpedia.org/resource/Template:Adrenergic_receptor_modulators +
, http://dbpedia.org/resource/Template:Monoamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Benzofuran_ethers_at_the_benzene_ring +
, http://dbpedia.org/resource/Category:5-HT1A_antagonists +
, http://dbpedia.org/resource/Category:5-HT2A_antagonists +
, http://dbpedia.org/resource/Category:4-Phenylpiperidines +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93dopamine_reuptake_inhibitors +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antidepressant +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/MIN-117?oldid=1085647288&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/MIN-117.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/MIN-117 +
|
| owl:sameAs |
https://global.dbpedia.org/id/xeuS +
, http://dbpedia.org/resource/MIN-117 +
, http://rdf.freebase.com/ns/m.0138thgp +
, http://yago-knowledge.org/resource/MIN-117 +
, http://www.wikidata.org/entity/Q20706886 +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
MIN-117 (known formerly as WF-516) is an i … MIN-117 (known formerly as WF-516) is an investigational antidepressant which is under development by for the clinical treatment of major depressive disorder (MDD). It is described as a 5-HT1A and 5-HT2A receptor antagonist and inhibitor of serotonin and dopamine reuptake, and is also reported to possess affinity for the α1A- and α1B-adrenergic receptors. As of May 2015, MIN-117 is in phase II clinical trials for MDD. In December 2019, Minerva announced that MIN-117 was no longer in clinical development for MDD after disappointing results in a phase IIb trial.isappointing results in a phase IIb trial.
|
| rdfs:label |
MIN-117
|
